Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ciba Vision (Switzerland) pushes harder for ophthalmic lasers:

This article was originally published in Clinica

Executive Summary

Ciba Vision (Switzerland) is to increase its interest in the emerging refractive laser market by making an unspecified additional investment in US manufacturer Autonomous Technologies. The two companies formed an alliance last year to enhance development of medical laser technology for the surgical correction of common visual disorders (see Clinica No 608, p 16). Under the new agreement, the companies will combine to promote Autonomous' tracker-assisted photorefractive keratectomy device. Some 50% of adults worldwide suffer some sort of vision disorder, says Ciba Vision.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT092027

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel